Adverse Event Reporting
| VAERS ID | 2136984 |
|---|---|
| Gender | Male |
| Age | 77 |
| StateCode | TX |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EN6198 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-02-25 |
| Onset | 2022-02-09 |
| Condition | Hospitalized Died |
Symptoms
- Pyrexia
- Dyspnoea
- COVID-19
- Atrial fibrillation
- Acute myocardial infarction
- Endotracheal intubation
- Death
- Pleural effusion
- Acute respiratory failure
- Distributive shock
Current Illness
Preexisting Conditions
Afib, HLD, OA
Other Medications
tylenol, chlorhexidine, docusate, ezetimibe, finasteride, gabapentin, HC/tylenol, hydromorphone,medrol dose pack, mupirocin, pantoprazole, xarelto, tapentadol, trazodone
Previous Vaccinations
Allergies
atorvastatin
Laboratory Data
Write-up
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death.
Patient received Pfizer Vaccine on 2/4/21 and 2/25/21.
Presented to ED 2/6/22 with SOB and sxs worsened over 3 weeks.
Previous Friday to admission began having fevers, prescribed azithromycin and inhalers.
Tested negative for covid 2-3 times.
Admitted for A-fib and acute hypoxic resp failure 2/2 Covid.
Required HFNC during admission, intubated 2/8.
STEMI 2/9 c/b distributive shock and bil.
pleural effusions.
Transitioned to comfort care.
Tx'd with decadron, solumedrol, baricitinib,cefepime and vancomycin.
Expired 02/09/22.